Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-029042
Filing Date
2021-11-17
Accepted
2021-11-17 06:02:56
Documents
66
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1083742
2 form10-q_001.jpg GRAPHIC 3351
3 ex10-1.htm EX-10.1 64903
4 ex31-1.htm EX-31.1 15282
5 ex31-2.htm EX-31.2 15418
6 ex32-1.htm EX-32.1 7452
7 ex32-2.htm EX-32.2 7545
8 ex10-1_001.jpg GRAPHIC 3563
  Complete submission text file 0001493152-21-029042.txt   5244693

Data Files

Seq Description Document Type Size
9 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mslp-20210930.xsd EX-101.SCH 39053
10 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mslp-20210930_cal.xml EX-101.CAL 52145
11 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mslp-20210930_def.xml EX-101.DEF 149190
12 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mslp-20210930_lab.xml EX-101.LAB 323604
13 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mslp-20210930_pre.xml EX-101.PRE 246019
14 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 731787
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

EIN.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53166 | Film No.: 211418333
SIC: 2834 Pharmaceutical Preparations